Company Overview

RadNet, Inc. is a U.S.-based diagnostic imaging services company that operates outpatient imaging centers and related healthcare technology businesses. The company provides medical imaging services across modalities including MRI, CT, PET/CT, mammography, ultrasound, X-ray, fluoroscopy, and nuclear medicine. RadNet primarily operates in the healthcare services and health technology industries, with revenue generated through imaging procedures reimbursed by commercial insurers, government healthcare programs, and patient self-pay arrangements. The company also develops and commercializes artificial intelligence-enabled diagnostic tools through its digital health operations.

RadNet’s primary business consists of operating a large network of freestanding outpatient imaging centers under regional brands and centralized operational platforms. Its strategic positioning is based on scale, payer relationships, operational efficiency, and integration of imaging services with technology-enabled workflow and AI applications. The company traces its origins to imaging center operations established in the 1980s and expanded significantly through acquisitions and regional consolidation. Over time, RadNet evolved from a regional imaging provider into one of the largest outpatient diagnostic imaging networks in the United States, while also expanding into AI-driven breast cancer screening and radiology software solutions through investments and acquisitions including DeepHealth.

Business Operations

RadNet organizes its operations primarily around diagnostic imaging services and digital health technology. The company’s core operating business includes imaging centers concentrated in major metropolitan markets such as California, New York, New Jersey, Maryland, Delaware, and Arizona. Revenue is primarily generated through fees associated with outpatient diagnostic imaging procedures. The company manages scheduling, radiology interpretation, billing, and administrative functions through centralized infrastructure intended to improve utilization and operating margins. RadNet also maintains relationships with hospitals, physician groups, and health systems through joint ventures and managed service agreements.

In addition to imaging center operations, RadNet operates technology-focused initiatives through DeepHealth, which develops AI-powered radiology and breast health software platforms. These technologies are intended to support early cancer detection, clinical workflow optimization, and imaging analytics. RadNet has also pursued partnerships and acquisitions to strengthen its software and AI capabilities, including transactions involving imaging informatics and breast screening technologies. The company’s assets include imaging equipment fleets, radiologist networks, proprietary workflow systems, and healthcare data infrastructure supporting both clinical and technology businesses.

Strategic Position & Investments

RadNet’s strategic direction centers on expanding outpatient imaging capacity, integrating artificial intelligence into radiology workflows, and increasing participation in value-based healthcare delivery models. The company has emphasized growth through acquisitions of imaging centers and regional consolidation strategies intended to increase market density and payer leverage. It has also invested substantially in digital health and AI-enabled diagnostics, particularly in breast cancer screening and imaging analytics. These initiatives are designed to improve operational efficiency while differentiating the company from smaller independent imaging providers.

A major component of RadNet’s investment strategy has involved the expansion of DeepHealth and related AI platforms. The company has pursued acquisitions and strategic investments aimed at building software capabilities in radiology interpretation support, workflow automation, and population health screening. RadNet has also participated in hospital joint ventures and long-term partnerships with healthcare systems to strengthen referral relationships and broaden patient access. Its technology initiatives reflect broader industry trends toward data-driven diagnostics and AI-assisted medical imaging interpretation.

Geographic Footprint

RadNet operates primarily in the United States, with imaging center concentrations in densely populated metropolitan regions. Its headquarters are located in El Segundo, California. Major operating regions include California, New York, New Jersey, Maryland, Delaware, and Arizona, where the company maintains extensive outpatient imaging networks. The company’s scale within these markets allows for regional brand recognition, centralized administrative operations, and integrated physician referral networks.

While RadNet’s direct clinical operations are concentrated domestically, its technology and AI initiatives have broader international relevance through software deployment opportunities and strategic collaborations. The company’s operational influence is strongest in North American outpatient imaging, though its digital health platforms are intended to support wider adoption across healthcare systems and imaging providers. Public disclosures indicate that the overwhelming majority of revenue is derived from U.S. operations.

Leadership & Governance

RadNet’s leadership team combines healthcare services management, radiology expertise, and technology strategy. The company was co-founded by Dr. Howard G. Berger, who has played a central role in its expansion and strategic development. Leadership has consistently emphasized consolidation of fragmented imaging markets, operational scale, and integration of advanced technology into diagnostic workflows. Corporate governance is overseen by a board of directors and executive leadership team with experience across healthcare operations, finance, and medical imaging.

Key executives include:

• Dr. Howard G. Berger – President and Chief Executive Officer
• Mark Stolper – Executive Vice President and Chief Financial Officer
• Norman R. Hames – Executive Vice President, Chief Operations Officer, and Secretary
• Dr. Jeffrey L. Linden – Executive Vice President and Chief Medical Officer
• Keshav S. Kolur – Chief Strategy and Artificial Intelligence Officer
• Babak Babaknia – Chief Executive Officer of DeepHealth

The company’s leadership strategy has focused on combining outpatient imaging scale with technology-enabled clinical innovation, particularly through AI applications intended to improve diagnostic accuracy, workflow efficiency, and patient screening outcomes.